Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,684 | 948 | 99.5% |
| Education | $87.49 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $2,328 | 106 | $0 (2022) |
| Alkermes, Inc. | $1,984 | 115 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,984 | 134 | $0 (2024) |
| Lundbeck LLC | $1,942 | 136 | $0 (2024) |
| AbbVie Inc. | $1,534 | 75 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $1,199 | 75 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $984.32 | 72 | $0 (2024) |
| Allergan, Inc. | $963.60 | 48 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $935.64 | 46 | $0 (2024) |
| ITI, Inc. | $834.00 | 46 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,589 | 105 | Janssen Pharmaceuticals, Inc ($473.45) |
| 2023 | $1,824 | 88 | ITI, Inc. ($434.57) |
| 2022 | $1,003 | 46 | ABBVIE INC. ($557.35) |
| 2021 | $1,462 | 73 | AbbVie Inc. ($712.02) |
| 2020 | $2,014 | 104 | Sunovion Pharmaceuticals Inc. ($675.69) |
| 2019 | $2,761 | 168 | Lundbeck LLC ($659.50) |
| 2018 | $3,144 | 184 | Sunovion Pharmaceuticals Inc. ($481.73) |
| 2017 | $2,974 | 189 | Sunovion Pharmaceuticals Inc. ($482.47) |
All Payment Transactions
957 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: CNS | ||||||
| 12/10/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: CNS | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: CNS | ||||||
| 12/03/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: CNS | ||||||
| 11/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Neuroscience | ||||||
| 11/26/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: CNS | ||||||
| 11/19/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: CNS | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CNS | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: CNS | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Neuropsychiatry | ||||||
| 11/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: Neuroscience | ||||||
| 10/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: CNS | ||||||
| 10/08/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: CNS | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,566 | 5,084 | $606,525 | $350,132 |
| 2022 | 10 | 1,391 | 6,334 | $724,625 | $417,372 |
| 2021 | 10 | 1,289 | 4,935 | $564,200 | $344,675 |
| 2020 | 13 | 1,197 | 4,951 | $527,675 | $306,982 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 335 | 1,979 | $197,900 | $101,356 | 51.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 192 | 530 | $68,650 | $52,059 | 75.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 163 | 759 | $75,975 | $50,314 | 66.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 263 | 266 | $66,875 | $37,929 | 56.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 367 | $45,775 | $26,947 | 58.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 102 | 363 | $36,300 | $20,249 | 55.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 381 | $38,100 | $15,709 | 41.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 86 | 118 | $20,925 | $12,734 | 60.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 117 | 117 | $20,475 | $11,308 | 55.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 51 | 70 | $17,500 | $9,761 | 55.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 65 | 84 | $8,400 | $5,739 | 68.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 23 | 23 | $5,750 | $3,557 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $2,125 | $1,436 | 67.6% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 13 | 14 | $1,775 | $1,033 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 186 | 1,346 | $168,225 | $101,474 | 60.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 240 | 1,650 | $165,000 | $87,506 | 53.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 184 | 1,235 | $123,500 | $71,489 | 57.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 142 | 423 | $52,950 | $36,615 | 69.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 203 | 205 | $51,250 | $33,787 | 65.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 109 | 492 | $49,200 | $29,590 | 60.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 39 | 638 | $52,150 | $20,726 | 39.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 69 | 94 | $16,625 | $10,618 | 63.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 67 | 68 | $17,000 | $9,356 | 55.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 66 | 67 | $11,725 | $6,018 | 51.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 26 | 36 | $9,000 | $5,283 | 58.7% |
About Dr. Michael Tolwin, M.D
Dr. Michael Tolwin, M.D is a Psychiatry healthcare provider based in Culver City, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497797427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Tolwin, M.D has received a total of $16,771 in payments from pharmaceutical and medical device companies, with $1,589 received in 2024. These payments were reported across 957 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($16,684).
As a Medicare-enrolled provider, Tolwin has provided services to 5,443 Medicare beneficiaries, totaling 21,304 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Culver City, CA
- Active Since 06/12/2006
- Last Updated 07/12/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497797427
Products in Payments
- VRAYLAR (Drug) $2,474
- LATUDA (Drug) $2,328
- INVEGA SUSTENNA (Drug) $1,377
- REXULTI (Drug) $1,255
- CAPLYTA (Drug) $1,177
- ARISTADA (Drug) $1,031
- INGREZZA (Drug) $935.64
- Aristada 441 mg (Drug) $849.69
- ABILIFY MAINTENA (Drug) $814.65
- Fanapt (Drug) $742.10
- AUSTEDO (Drug) $504.20
- INVEGA TRINZA (Drug) $421.88
- Trintellix (Drug) $419.16
- HETLIOZ (Drug) $354.31
- TRINTELLIX (Drug) $343.91
- PERSERIS (Drug) $265.60
- BRINTELLIX (Drug) $199.98
- Wakix (Drug) $192.86
- ABILIFY MYCITE (Drug) $186.72
- NUEDEXTA (Drug) $145.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Culver City
Dr. Arthur Kopp, M.d, M.D
Psychiatry — Payments: $7,528
Robert Trichter, M.d, M.D
Psychiatry — Payments: $4,715
Dr. Anita Red, Md, MD
Psychiatry — Payments: $1,367
Dr. Beverly Reader, M.d, M.D
Psychiatry — Payments: $1,058
Jonathan Shaywitz, Md, MD
Psychiatry — Payments: $798.33
Jesus Exposito Cespedes, M.d, M.D
Psychiatry — Payments: $720.43